77
Pharma & HealthcareBuy
SBI Healthcare Opportunities
SBI · Direct–Growth · rank #2 of 18 by Smart Score
Trailing returns
1 Year
14.8%
+14.2% vs index
3 Years
24.7%
+12.5% vs index
5 Years
17.4%
+5.5% vs index
Since launch
18.2%
Year-by-year performance
2021
+21.5%-9.1% vs index
2022
-5.0%-8.8% vs index
2023
+39.7%+13.2% vs index
2024
+43.8%+28.1% vs index
2025
-2.5%-10.2% vs index
2026
+19.8%+21.5% vs index
Why this score
SBI Healthcare Opportunities scores 77/100 — #2 of 18 Pharma & Healthcare fund (Buy). It stands out for 5y return and 3y return — beating 94% of peers on 5y return. It has no major weak spot vs the category.
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return17.42% · 94th percentile in category
3Y return24.67% · 75th percentile in category
Sharpe ratio1.27 · 91st percentile in category
Fund size4997.72 Cr · 86th percentile in category
Sortino ratio2.02 · 84th percentile in category
Volatility14.86 · 62nd percentile in category